Mike-andrew A. Westhoff
Albert Einstein Allee 23
Ulm, BW 89081, Germany
Ulm, BW 89081, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications
Correction: Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells.
Journal: Oncogene
Published: November 12, 2025
Core2Edge: a human glioblastoma organoid-brain slice model capturing infiltration and transcriptional heterogeneity from core to single-cell dispersion.
Journal: Nature protocols
Published: July 19, 2025
CDK12 regulates cellular metabolism to promote glioblastoma growth.
Journal: JCI insight
Published: January 02, 2025
Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical note.
Journal: PloS one
Published: November 11, 2024
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy.
Journal: Signal transduction and targeted therapy
Published: November 07, 2024
The Potential Role of the Extracellular Matrix Glycoprotein Reelin in Glioblastoma Biology.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 06, 2024
Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma.
Journal: NPJ precision oncology
Published: January 10, 2024
Curriculum "Tracheostomy management in dysphagia therapy"
Journal: Der Nervenarzt
Published: December 05, 2023
The Alcatraz-Strategy: a roadmap to break the connectivity barrier in malignant brain tumours.
Journal: Molecular oncology
Published: October 17, 2023
Tonabersat enhances temozolomide-mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibition.
Journal: Molecular oncology
Published: October 09, 2023
Last Updated: 09/26/2026